Rani Therapeutics Holdings reported total assets of $52.53M and total liabilities of $11.18M for the quarter ended Sep 2026, up 418.1% year over year. This balance sheet covers 26 quarters of results from Jun 2020 through Sep 2026, standardized by Business Quant from the company’s SEC filings.
| Balance SheetBalance Sheet | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 | Sep2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||||||||
| Current Assets | ||||||||||||||||||||||||||
| Cash & EquivalentsCash & Equiv. | 117.45M | 107.84M | 97.18M | 27.22M | 27.01M | 18.98M | 7.55M | 4.97M | 5.86M | 6.88M | 4.51M | 4.28M | 3.76M | 10.11M | 10.22M | 4.14M | 18.62M | 43.40M | 53.40M | 45.30M | ||||||
| Short-term InvestmentsInvestments (Current) | 98.50M | 97.29M | 46.51M | 46.51M | 46.51M | 25.78M | 25.78M | 25.78M | ||||||||||||||||||
| Cash & Current Investments | 117.45M | 107.84M | 97.18M | 27.22M | 125.51M | 18.98M | 7.55M | 102.26M | 5.86M | 53.39M | 51.03M | 50.79M | 3.76M | 35.89M | 36.00M | 29.92M | 18.62M | 43.40M | 53.40M | 45.30M | ||||||
| Receivables - NetNet Receivables | 0.60M | 2.04M | 2.04M | 2.04M | 1.96M | |||||||||||||||||||||
| Receivables - OtherOther Receivables | 0.43M | |||||||||||||||||||||||||
| Receivables | 0.43M | 0.60M | 2.04M | 2.04M | 2.04M | 1.96M | ||||||||||||||||||||
| Current Deferred Tax AssetsCurrent Deferred Tax | -28.67M | -52.82M | -61.00M | |||||||||||||||||||||||
| Prepaid Assets | 2.14M | 1.42M | 0.81M | 2.55M | 2.44M | 1.75M | 1.77M | 2.70M | 2.31M | 1.81M | 1.13M | 1.97M | 1.68M | 1.33M | 0.86M | 0.81M | 1.57M | 1.65M | 1.09M | 1.23M | ||||||
| Current Assets | 119.60M | 109.26M | 97.99M | 100.72M | 100.92M | 89.04M | 76.37M | 63.22M | 50.85M | 41.39M | 32.03M | 32.37M | 29.74M | 17.78M | 11.07M | 4.96M | 53.32M | 47.09M | 56.52M | 48.48M | ||||||
| Non-Current Assets | ||||||||||||||||||||||||||
| Construction in Progress | 3.50M | 0.00M | 0.03M | 0.03M | 0.03M | 0.09M | 0.31M | |||||||||||||||||||
| Property, Plant & Equipment (Net)PP&E (Net) | 4.61M | 4.89M | 5.35M | 5.68M | 6.04M | 5.99M | 5.94M | 6.26M | 6.11M | 5.91M | 5.70M | 5.50M | 1.55M | 1.35M | 1.14M | 0.92M | 0.74M | 0.60M | 0.53M | 0.66M | ||||||
| Long-Term Investments | 25.23M | 44.92M | 45.47M | |||||||||||||||||||||||
| Goodwill | 0.04M | 0.07M | ||||||||||||||||||||||||
| Intangibles | 104.00 | 0.10M | 0.10M | 0.10M | 0.10M | 0.10M | ||||||||||||||||||||
| Goodwill & Intangibles | 0.04M | 0.07M | 104.00 | 0.10M | 0.10M | 0.10M | 0.10M | 0.10M | ||||||||||||||||||
| Long-Term Deferred Tax | 28.69M | 52.82M | 61.00M | |||||||||||||||||||||||
| Other Non-Current Assets | 0.50M | 0.50M | 0.25M | 0.25M | 0.25M | 0.25M | 0.25M | 0.25M | 0.29M | 0.25M | 0.25M | 0.25M | 0.25M | 0.25M | ||||||||||||
| Non-Current Assets | 4.61M | 6.05M | 6.35M | 7.48M | 7.10M | 7.41M | 7.13M | 7.21M | 7.07M | 12.12M | 11.69M | 11.17M | 6.89M | 6.34M | 5.83M | 5.18M | 5.30M | 4.79M | 4.32M | 4.05M | ||||||
| Assets | 124.21M | 115.31M | 104.34M | 108.20M | 108.03M | 96.45M | 83.51M | 70.44M | 57.92M | 53.51M | 43.73M | 43.54M | 36.63M | 24.13M | 16.90M | 10.14M | 58.62M | 51.88M | 60.84M | 52.53M | ||||||
| Liabilities | ||||||||||||||||||||||||||
| Current Liabilities | ||||||||||||||||||||||||||
| Accounts Payables | 1.08M | 1.27M | 1.44M | 1.79M | 1.46M | 1.51M | 1.04M | 1.41M | 0.65M | 0.81M | 0.51M | 1.57M | 1.36M | 1.52M | 1.80M | 2.47M | 0.31M | 0.86M | 1.05M | 0.45M | ||||||
| Notes Payables | 3.46M | 4.95M | 1.20M | 5.22M | ||||||||||||||||||||||
| Payables | 1.08M | 1.27M | 1.44M | 1.79M | 1.46M | 1.51M | 1.04M | 4.86M | 0.65M | 5.76M | 1.71M | 6.78M | 1.36M | 1.52M | 1.80M | 2.47M | 0.31M | 0.86M | 1.05M | 0.45M | ||||||
| Accumulated Expenses | 1.43M | 2.10M | 3.22M | 4.36M | 2.35M | 2.72M | 3.84M | 3.93M | 1.73M | 2.76M | 2.42M | 1.87M | 2.07M | 2.29M | 2.64M | 2.09M | 3.94M | 4.71M | 3.14M | 4.16M | ||||||
| Other Accumulated Expenses | 0.13M | 0.14M | 0.03M | 0.06M | 0.05M | 254.00 | 0.28M | 0.05M | 0.10M | 0.07M | 0.05M | |||||||||||||||
| Short term Debt | 1.22M | 4.90M | 8.59M | 12.29M | 14.77M | 15.00M | 15.00M | 15.00M | 13.54M | |||||||||||||||||
| Current Leases | 1.01M | 0.79M | 0.72M | 1.22M | 1.36M | 1.41M | 1.46M | 1.33M | 1.19M | 1.05M | 1.59M | 1.46M | 1.33M | 1.20M | ||||||||||||
| Current Taxes | 0.04M | -300.00 | -400.00 | |||||||||||||||||||||||
| Current Deferred Revenue | 0.60M | 6.83M | 6.83M | 5.12M | 3.42M | |||||||||||||||||||||
| Current Deferred Tax LiabilityCurrent Deferred Tax | -100.00 | |||||||||||||||||||||||||
| Total Current Liabilities | 2.64M | 4.16M | 5.35M | 7.19M | 4.82M | 5.15M | 5.74M | 7.35M | 7.99M | 13.38M | 16.58M | 20.21M | 19.89M | 20.13M | 20.62M | 19.14M | 12.67M | 13.86M | 10.64M | 9.22M | ||||||
| Non-Current Liabilities | ||||||||||||||||||||||||||
| Non-Current Debt | 14.09M | 29.15M | 29.21M | 29.27M | 28.10M | 24.48M | 20.85M | 17.21M | 13.54M | 9.61M | 5.92M | 2.23M | ||||||||||||||
| Non-Current Deferred Revenue | 1.71M | |||||||||||||||||||||||||
| Pension | 0.31M | 0.35M | 2.65M | 3.43M | 2.05M | 3.09M | ||||||||||||||||||||
| Preferred Stock Liabilities | ||||||||||||||||||||||||||
| Minority Interest | 74.16M | 57.26M | 50.84M | 44.41M | 37.15M | 30.87M | 24.08M | 17.27M | 12.58M | 7.14M | 2.72M | 2.66M | 1.50M | -2.29M | -3.58M | -4.11M | 8.50M | 7.14M | 8.75M | 7.38M | ||||||
| Operating Leases | 0.51M | 0.34M | 0.32M | 0.06M | 0.50M | 0.34M | 0.17M | 4.75M | 4.39M | 4.02M | 3.64M | 3.42M | 3.20M | 2.97M | 2.73M | 2.48M | 2.22M | 1.95M | ||||||||
| Other Non-Current Liabilities | 0.33M | 0.34M | 0.33M | 0.32M | 0.31M | |||||||||||||||||||||
| Total Non-Current Liabilities | 32.81M | 16.77M | 16.01M | 12.54M | 10.87M | |||||||||||||||||||||
| Total Liabilities | 2.64M | 4.67M | 5.69M | 21.60M | 34.02M | 34.86M | 35.34M | 35.62M | 32.47M | 38.98M | 38.18M | 37.77M | 33.14M | 29.47M | 26.05M | 22.11M | 17.11M | 16.34M | 12.86M | 11.18M | ||||||
| Shareholder's Equity | ||||||||||||||||||||||||||
| Total Debt | 14.09M | 29.15M | 29.21M | 29.27M | 32.78M | 29.38M | 34.39M | 30.70M | 33.52M | 24.61M | 20.92M | 17.23M | 13.54M | |||||||||||||
| Common Equity | 121.57M | 110.64M | 98.65M | 86.61M | 74.00M | 61.59M | 48.17M | 34.82M | 25.44M | 14.54M | 5.55M | 5.78M | 3.49M | -5.35M | -9.15M | -11.97M | 41.51M | 35.54M | 47.99M | 41.35M | ||||||
| Liabilities and Shareholders Equity | 124.21M | 115.31M | 104.34M | 108.20M | 108.03M | 96.45M | 83.51M | 70.44M | 57.92M | 53.51M | 43.73M | 43.54M | 36.63M | 24.13M | 16.90M | 10.14M | 58.62M | 51.88M | 60.84M | 52.53M | ||||||
| Retained Earnings | -8.33M | -14.60M | -22.20M | -30.13M | -38.92M | -47.30M | -56.60M | -65.80M | -72.89M | -80.40M | -87.20M | -94.00M | -102.91M | -110.20M | -116.90M | -122.30M | -132.58M | -139.61M | -147.00M | -154.73M | ||||||
| Preferred Shares |
Pull Rani Therapeutics Holdings's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=RANI&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "RANI", "statement": "BS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/statements?ticker=RANI&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();